Study to Test Whether Shoes Protect Children Against Hookworm Infection on Pemba Island, Zanzibar (SKIP)

June 1, 2013 updated by: Bird, Christopher

Shoes for Kids on the Island of Pemba (SKIP): A Pragmatic, Cluster Randomised Controlled Trial to Test if Shoes Reduce Hookworm Infection and Transmission in School-aged Children on Pemba Island, Zanzibar

Small association studies have hypothesised that shoes protect against hookworm infection. The purpose of this pragmatic study was determine, under field conditions, whether school-age children on Pemba Island, Zanzibar, would wear shoes and if shoes protected them against hookworm infection.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Aim: To carry out a cluster randomised controlled trial (non-blinded) to test under field conditions whether the provision of shoes to school-aged children on Pemba Island, Zanzibar, an area of high hookworm prevalence and anaemia, could reduce the transmission, incidence and disease burden of hookworm infection among this susceptible population.

Methods:

Setting: Pemba Island is the northern of the two main islands that make up the Zanzibar archipelago, situated in the Indian Ocean and close to the coast of East Africa, just below the equator. The climate is tropical and humid and the island has two rainy seasons, from March-June (Masika) and October-December (Vuli). Humidity is high, up to 1000mm during the Masika rains. Economic activities are mainly agriculture and fishing and considerable improvements to infrastructure - roads and electricity - have been made in recent years. The island's population totalled 460,196 in 2008, of whom 50 percent were children aged <15 years. Zanzibar is an autonomous part of the United Republic of Tanzania and on the mainland, the under 5 mortality rate (U5MR) is 81 per 1,000 live births but is substantially higher on Zanzibar at 116 per 1,000 live births. The area is highly endemic for soil transmitted helminths - a recent study on neighbouring Unguja Island found three-quarters of rural inhabitants and half of urban inhabitants to be infected with parasitic worms, despite 15 years of mass drug treatment. Other risk factors for concomitant anaemia are poor nutrition, focal areas of Schistosoma haematobium transmission and malaria, although recent control efforts have made impressive reductions in malaria transmission (reduced to 0.8% prevalence in 2007).

Study schools (clusters): 12 government primary schools from across the entire island were identified for the trial, where hookworm prevalence in a previous survey totalled >50%: Mizingani, Ng'ombeni, Chambani, Uwandani, Bagamoyo, Shumba Viamboni, Mkanyageni, Ziwani, Wesha, Tumbe, Wingwi, and Ngwachani.

Study design: Pragmatic, cluster (non-blinded) randomised controlled trial with school-aged children randomized to either the intervention (a pair of shoes alongside standard care) or standard care (periodic de-worming with antihelminthics and health education). Children already wearing shoes were advised to continue to do so in the control arm.

Sample size: The study aimed for 80% power and 5% significance, adjusted for cluster design, to look for a 25% reduction in hookworm prevalence, a 25% reduction in hookworm incidence and a 40% reduction in the geometric mean of residual hookworm infection intensity in the intervention arm, based on survey data at selected schools which showed >50% prevalence of hookworm infection in 2010. Using a sample size calculation in Stata 11.2 (StataCorp, 2009), adjusted for cluster design, the study needed to enrol an average 77 children in each of the 12 clusters (n=924, 462 in each arm), using a correlation coefficient of 0.01. A greater number of clusters would have been preferable but available resources limited the study design to 12 schools.

Inclusion criteria: Healthy school children were randomly selected (but stratified by class and sex) from 12 schools selected for enrolment into the trial. Stratification took place as follows: Class 1 at each school was called in and boys and girls divided into two groups. The children were then asked to count off '1', '2' along the line they had formed up in and then either the 1s or the 2s were asked to file out. The first 10 children in each group remaining (10 girls and 10 boys so 20 children in each class) were given a sample pot and a consent form to take home to their parents. This was repeated for all 5 primary school classes at each of the 12 schools.

Exclusions: children whose parents did not consent to the participation of their child in the trial or children who have had a life-threatening allergic reaction to Albendazole.

Baseline characteristics: were collected from enrolled children attending schools in both arms. A short questionnaire was used to collect information on age, sex, housing characteristics and other measures of wealth, sanitation at home and at school, footwear use (both observed and subjective), history of recent illness, when the child last had an antihelminthic drug (for Schistosomiasis or STHs) and bed net use.

Parasitology: 1 stool sample from each child at baseline (July 2011) and six months after shoe distribution (October 2012) was examined at the Public Health Laboratory (PHL), Pemba Island, using the Kato-Katz method, to measure both prevalence of soild transmitted helminths (STH) and STH infection intensity in eggs/gram of stool. To minimise hookworm egg loss, the stool was collected at the beginning of the school day and placed in a coolbox while waiting for transfer to Pemba's Public Health Laboratory and then processed on arrival. An average 10 percent of sample slides were re-checked for quality control by the most experienced microscopist.

Randomisation of clusters: Simple randomisation was used where schools were entered into an Excel (Microsoft, 2010) spreadsheet and the "RAND" function was used to assign random numbers between 0 and 1. The six lowest numbers were assigned to the intervention arm and the six highest were assigned to the control arm before baseline data was gathered. Given the nature of the intervention, the trial is non-blinded.

Data handling: Baseline data was analysed using Stata 11.2 (StataCorp, 2009). Subsequent data was analysed using SOFA Statistics Version 1.3.2 (Paton-Simpson and Associatiates Ltd, 2012). Data containing identity numbers but no names was stored on password-protected computers and available only to the prinicipal investigator, the co-principal investigator and the study's supervisor. Study registration details (to identify children with heavy hookworm load and for subsequent follow-up) are stored at the Public Health Laboratory, Pemba island.

Shoe distribution: Shoes were distributed to all schools' pupils in the intervention arm (ie not only those being monitored in the trial, with approximately 6,500 pupils receiving a pair of shoes) to ensure trial subjects did not stand out from their peers; government sponsored de-worming and healthcare education (one stat dose Albendazole 400mg) continued for all schools' pupils in both intervention and control arms.

Ethics approval: The study protocol was approved by both the Zanzibar Medical Research and Ethics Committee (ZAMREC) and the MSc Ethics Committee of the London School of Hygiene and Tropical Medicine. Approval was also sought and granted from Zanzibar's Ministry of Education at a presentation and meeting of ministry officials and school head teachers at the Public Health laboratory, Pemba Island.

Consent: Consent forms, providing a detailed description of the trial in plain language and translated into Swahili, were distributed to children eligible for the study (see enrolment below) to take home to their parents or primary carers. It was explained to parents that they were free to remove their children from the study at any time. A telephone number to the research team was made available to parents (and was used on several occasions) in case parents had any questions or concerns. A child was enrolled in the study only if they brought a signed consent form with their stool sample.

Safety monitoring and treatment: All children in both the intervention and control arms of the trial were treated for soil transmitted helminths as part of the Zanzibar government's ongoing mass drug treatment programme. Both shoes and Albendazole (de-worming drug) have established safety profiles and therefore monitoring between each phases of the trial was not considered necessary. Children in the study found to have heavy hookworm infection (>4,000 eggs per gram of stool) were treated by a paediatrician with stat Mebendazole (Vermox 100mg twice daily for 3 days) and 10 days of Ferrous gluconate syrup (10mls twice daily - dosing for 6-18 year-olds) directly following diagnosis.

Study Type

Interventional

Enrollment (Actual)

1056

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pemba Island, Zanzibar
      • Chake Chake, Pemba Island, Zanzibar, Tanzania
        • Public Health Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • school-aged children attending one of the 12 schools identified for the study

Exclusion Criteria:

  • lack of consent from family
  • allergy to Albendazole

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Standard care
Experimental: Shoes
A unisex canvas slip-on with a sturdy sole.
Other Names:
  • 'Giving Shoe' produced by TOMS Shoes, Los Angeles, California, USA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction in hookworm prevalence and intensity of infection in intervention arm
Time Frame: 6 months
Prevalence of hookworm measured as a percentage in both intervention and control arms; intensity of infection measured as the geometric mean hookworm load in eggs per gram of stool (via Kato-Katz method).
6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Use of shoes by children in intervention arm
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher K Bird, MBBS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Actual)

October 1, 2012

Study Completion (Actual)

October 1, 2012

Study Registration Dates

First Submitted

April 1, 2013

First Submitted That Met QC Criteria

June 1, 2013

First Posted (Estimate)

June 5, 2013

Study Record Updates

Last Update Posted (Estimate)

June 5, 2013

Last Update Submitted That Met QC Criteria

June 1, 2013

Last Verified

June 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hookworm

Clinical Trials on Shoes

Subscribe